JNJ Presents IMAAVY Data
Johnson & Johnson presents new IMAAVY data at European Academy of Neurology Congress, showing sustained disease control in generalized myasthenia gravis
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.